Fundraising Fox
Optobio
Ann Arbor, US · 1 known investors
Find your way into Optobio
Sign up to see every warm intro you have to Optobio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Optobio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Optobio makes the Xpress ELISA, a 48-channel automated ELISA instrument with an integrated chemiluminescence detector that delivers results in under an hour using small sample volumes. The device supports multiplexed or single-plexed assays with 18 validated tests for laboratory immunoassay applications.
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention | Phase I | 2022 | $256.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Optobio do?
- Optobio makes the Xpress ELISA, a 48-channel automated ELISA instrument with an integrated chemiluminescence detector that delivers results in under an hour using small sample volumes. The device supports multiplexed or single-plexed assays with 18 validated tests for laboratory immunoassay applications.
- Who are Optobio's investors?
- Optobio's investors include Invest Michigan.
- Where is Optobio headquartered?
- Optobio is headquartered in Ann Arbor, US.